Lv4
590 积分 2025-02-10 加入
Anatomy of hot spots in protein interfaces
14天前
已完结
Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity
14天前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
14天前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
20天前
已完结
Erythrocyte–antibody conjugates to overcome immunotherapy resistance
20天前
已完结
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity
21天前
已完结
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
21天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
24天前
已完结
Thrombospondin-1–CD47 signaling contributes to the development of T cell exhaustion in cancer
26天前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
1个月前
已完结
皖公网安备34019202002308
